All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DUOL / Duolingo, Inc.
|
|
|
|
|
|
|
|
| LYEL / Lyell Immunopharma, Inc.
|
|
|
|
|
|
|
|
| GTLB / GitLab Inc.
|
|
|
|
|
|
|
|
| TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
| DM / Desktop Metal, Inc.
|
|
|
|
|
|
|
|
| FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| PATH / UiPath Inc.
|
|
|
|
|
|
|
|
| TCRX / TScan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PL / Planet Labs PBC
|
|
|
|
|
|
|
|
| SPRO / Spero Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRWD / CrowdStrike Holdings, Inc.
|
|
|
|
|
|
|
|
| OSCR / Oscar Health, Inc.
|
|
|
|
|
|
|
|
| HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
| HOOD / Robinhood Markets, Inc.
|
|
|
|
|
|
|
|
| FRSH / Freshworks Inc.
|
|
|
|
|
|
|
|
| BHIL / Benson Hill, Inc.
|
|
|
|
|
|
|
|
| OPRT / Oportun Financial Corporation
|
|
|
|
|
|
|
|
| LYFT / Lyft, Inc.
|
|
|
|
|
|
|
|
| DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
| AMPL / Amplitude, Inc.
|
|
|
|
|
|
|
|
| VLD / Velo3D, Inc.
|
|
|
|
|
|
|
|
| HLTH / Cue Health Inc.
|
|
|
|
|
|
|
|
| GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RGEN / Repligen Corporation
|
|
|
|
|
|
|
|
| NVTAQ / Invitae Corporation
|
|
|
|
|
|
|
|
| SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
| EVLO / Evelo Biosciences, Inc.
|
|
|
|
|
|
|
|
| BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MOND / Mondee Holdings, Inc.
|
|
|
|
|
|
|
|
| RAPT / RAPT Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NEWR / New Relic Inc
|
|
|
|
|
|
|
|
| TNYA / Tenaya Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RANI / Rani Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
| IVVD / Invivyd, Inc.
|
|
|
|
|
|
|
|
| ME / 23andMe Holding Co.
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
| PRME / Prime Medicine, Inc.
|
|
|
|
|
|
|
|
| MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
| EQRX / EQRx Inc
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| SNOW / Snowflake Inc.
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| QNCX / Quince Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
| VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
